P2RX7 and rheumatoid arthritis: Previous studies in systemic inflammatory diseases have demonstrated that the ATP-induced monocyte P2X7 receptor response (as measured by IL-1β secretion) is attenuated in SLE, but enhanced in RA [45,53], and that this response is influenced by P2RX7 polymorphism.